Comparative Bioavailability and Benefits on Mental Functions of Novel Extended-Release Caffeine Capsules against Immediate-Release Caffeine Capsules: An Open-Label, Randomized, Cross-over, Single-Dose Two-Way Crossover Study.

Present study aimed compared pharmacokinetic profile of sustained-release CaffXtend® capsules (SR-Caffeine) with immediate-release caffeine capsules (IR-Caffeine), and the effect of SR-caffeine on memory, motivation, concentration, and attention. This open-label, randomized, single-dose, two-treatme...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Dietary Supplements Vol. 21; no. 1; pp. 13 - 28
Autores principales: Thanawala, Shefali, Shah, Rajat, Abiraamasundari, R., Senthurselvi, R., Desomayanandam, Prabakaran
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: Taylor & Francis Ltd 2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=174725270&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 174725270
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        19390211
        2Y62
      jtl: Journal of Dietary Supplements
      issn: 19390211
      maglogo: N
    pubinfo:
      dt: 2024
      vid: 21
      iid: 1
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        174725270
        161138361
        174725270
        174725270
        10.1080/19390211.2022.2160529
        174725270
      ppf: 13
      ppct: 15
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Comparative Bioavailability and Benefits on Mental Functions of Novel Extended-Release Caffeine Capsules against Immediate-Release Caffeine Capsules: An Open-Label, Randomized, Cross-over, Single-Dose Two-Way Crossover Study.
      aug:
        au:
          Thanawala, Shefali
          Shah, Rajat
          Abiraamasundari, R.
          Senthurselvi, R.
          Desomayanandam, Prabakaran
        affil: Nutriventia Limited Mumbai, Andheri, Maharashtra, India
      sug:
        subj:
          Caffeine Administration and Dosage
          Caffeine Adverse Effects
          Delayed-Action Preparations Adverse Effects
          Capsules
          Caffeine Pharmacokinetics
          Memory
          Motivation
          Attention
          Drug Efficacy
          Human
          Cross Sectional Studies
          Randomized Controlled Trials
          Random Assignment
          Crossover Design
          India
          Visual Analog Scaling
          Blood Specimen Collection
          Descriptive Statistics
          Confidence Intervals
          Affect
          Mental Fatigue
          Data Analysis Software
          Anthropometry
          Food Intake
          Questionnaires
          Caffeine Blood
          Plasma
          Analytic Sample Preparation Methods
          Liquid Chromatography-Mass Spectrometry
          Autoanalysis
          Analysis of Variance
          Adult
          Headache
          Dietary Supplementation
          Funding Source
          Adult: 19-44 years
      ab: Present study aimed compared pharmacokinetic profile of sustained-release CaffXtend® capsules (SR-Caffeine) with immediate-release caffeine capsules (IR-Caffeine), and the effect of SR-caffeine on memory, motivation, concentration, and attention. This open-label, randomized, single-dose, two-treatment, two-sequence, two-period, two-way crossover oral bioavailability study block randomized (1:1) healthy subjects (N = 15) to receive SR-Caffeine (200 mg) and IR-Caffeine (200 mg). Blood samples were collected at 0.25, 0.50, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12, 24, 36 and 48 h in each period. Primary study outcome included comparing relative bioavailability of SR-Caffeine 200 mg and IR-Caffeine 200 mg under fasting conditions, and changes in caffeine research visual analogue scale (Caff-VAS) scores ('relaxed', 'alert', 'jittery', 'tired', 'tense', 'headache', 'overall mood' and 'mentally fatigued') were also evaluated. Fifteen subjects completed the study. Mean tmax was 4.08 ± 2.13h for SR-Caffeine compared to 0.83 ± 0.39h for IR-Caffeine, (p < 0.0001). Similarly, mean t½ was 7.07 ± 3.48h for SR-Caffeine compared to 5.78 ± 2.11h for IR-Caffeine (p = 0.04189). However, total exposure was similar for SR-Caffeine and IR-Caffeine (90% CI: 89.89-120.50% to 94.49-123.82% for geometric least square mean of ln-transformed AUC0-t and AUC0-∞). In the Caff-VAS evaluation, the SR-Caffeine group showed significantly better scores for 'jitteriness', 'tiredness', 'alertness' and 'overall mood' for 8-12 h than the IR-Caffeine group. No adverse events were reported. Results demonstrated sustained release of caffeine over 24 h from SR-Caffeine as compared to IR-Caffeine, which showed significant improvements in the scores for 'relaxed', 'alertness' and 'overall mood' and significantly lower scores for the parameters-'jittery' and 'tired' for extended period.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N